BKYI Quote, Financials, Valuation and Earnings

Iveda Solutions has a net margin of -45.83% compared to BIO-key International's net margin of -53.82%. BIO-key International's return on equity of -207.44% beat Iveda Solutions's return on equity of -98.46%.

BIO-key International has a consensus price target of $2.00, signalling upside risk potential of 144.2%. On the other hand Iveda Solutions has an analysts' consensus of -- which suggests that it could grow by 286.47%. Given that Iveda Solutions has higher upside potential than BIO-key International, analysts believe Iveda Solutions is more attractive than BIO-key International.

BIO-key International has a beta of 0.240, which suggesting that the stock is 75.964% less volatile than S&P 500. In comparison Iveda Solutions has a beta of 0.793, suggesting its less volatile than the S&P 500 by 20.718%.

BIO-key International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Iveda Solutions offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BIO-key International pays -- of its earnings as a dividend. Iveda Solutions pays out -- of its earnings as a dividend.

BIO-key International quarterly revenues are $1.6M, which are larger than Iveda Solutions quarterly revenues of $1.5M. BIO-key International's net income of -$736.6K is higher than Iveda Solutions's net income of -$793.7K. Notably, BIO-key International's price-to-earnings ratio is -- while Iveda Solutions's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BIO-key International is 0.36x versus 0.70x for Iveda Solutions. Usually stocks with elevated PS ratios are considered overvalued.

NAPCO Security Technologies has a net margin of -45.83% compared to BIO-key International's net margin of 23.03%. BIO-key International's return on equity of -207.44% beat NAPCO Security Technologies's return on equity of 26.3%.

BIO-key International has a consensus price target of $2.00, signalling upside risk potential of 144.2%. On the other hand NAPCO Security Technologies has an analysts' consensus of $27.70 which suggests that it could fall by -2.77%. Given that BIO-key International has higher upside potential than NAPCO Security Technologies, analysts believe BIO-key International is more attractive than NAPCO Security Technologies.

BIO-key International has a beta of 0.240, which suggesting that the stock is 75.964% less volatile than S&P 500. In comparison NAPCO Security Technologies has a beta of 1.406, suggesting its more volatile than the S&P 500 by 40.616%.

BIO-key International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NAPCO Security Technologies offers a yield of 1.67% to investors and pays a quarterly dividend of $0.13 per share. BIO-key International pays -- of its earnings as a dividend. NAPCO Security Technologies pays out 26.61% of its earnings as a dividend. NAPCO Security Technologies's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

BIO-key International quarterly revenues are $1.6M, which are smaller than NAPCO Security Technologies quarterly revenues of $44M. BIO-key International's net income of -$736.6K is lower than NAPCO Security Technologies's net income of $10.1M. Notably, BIO-key International's price-to-earnings ratio is -- while NAPCO Security Technologies's PE ratio is 23.35x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BIO-key International is 0.36x versus 5.79x for NAPCO Security Technologies. Usually stocks with elevated PS ratios are considered overvalued.

Universal Security Instruments has a net margin of -45.83% compared to BIO-key International's net margin of -16.92%. BIO-key International's return on equity of -207.44% beat Universal Security Instruments's return on equity of -26.44%.

BIO-key International has a consensus price target of $2.00, signalling upside risk potential of 144.2%. On the other hand Universal Security Instruments has an analysts' consensus of -- which suggests that it could fall by --. Given that BIO-key International has higher upside potential than Universal Security Instruments, analysts believe BIO-key International is more attractive than Universal Security Instruments.

BIO-key International has a beta of 0.240, which suggesting that the stock is 75.964% less volatile than S&P 500. In comparison Universal Security Instruments has a beta of -0.206, suggesting its less volatile than the S&P 500 by 120.557%.

BIO-key International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Universal Security Instruments offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BIO-key International pays -- of its earnings as a dividend. Universal Security Instruments pays out -- of its earnings as a dividend.

BIO-key International quarterly revenues are $1.6M, which are smaller than Universal Security Instruments quarterly revenues of $5.5M. BIO-key International's net income of -$736.6K is higher than Universal Security Instruments's net income of -$936.6K. Notably, BIO-key International's price-to-earnings ratio is -- while Universal Security Instruments's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BIO-key International is 0.36x versus 0.25x for Universal Security Instruments. Usually stocks with elevated PS ratios are considered overvalued.

VerifyMe has a net margin of -45.83% compared to BIO-key International's net margin of -12.82%. BIO-key International's return on equity of -207.44% beat VerifyMe's return on equity of -32.13%.

BIO-key International has a consensus price target of $2.00, signalling upside risk potential of 144.2%. On the other hand VerifyMe has an analysts' consensus of $1.38 which suggests that it could grow by 92.85%. Given that BIO-key International has higher upside potential than VerifyMe, analysts believe BIO-key International is more attractive than VerifyMe.

BIO-key International has a beta of 0.240, which suggesting that the stock is 75.964% less volatile than S&P 500. In comparison VerifyMe has a beta of 0.522, suggesting its less volatile than the S&P 500 by 47.817%.

BIO-key International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VerifyMe offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BIO-key International pays -- of its earnings as a dividend. VerifyMe pays out -- of its earnings as a dividend.

BIO-key International quarterly revenues are $1.6M, which are smaller than VerifyMe quarterly revenues of $4.5M. BIO-key International's net income of -$736.6K is lower than VerifyMe's net income of -$571K. Notably, BIO-key International's price-to-earnings ratio is -- while VerifyMe's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BIO-key International is 0.36x versus 0.34x for VerifyMe. Usually stocks with elevated PS ratios are considered overvalued.